A Point-of-Care LNP Formulation for Rapid Manufacturing of Personalized Cancer Vaccines
- Showcasing an off‑the‑shelf lipid nanoparticle platform, eliminating the need for bespoke formulation development
- Personalized vaccines are rapidly manufactured by simply incorporating patient‑specific mRNAs
- This modular approach dramatically shortens manufacturing timelines and significantly lowers production costs for personalized cancer vaccines